semaglutide lawsuit 2025 Rybelsus - July 2026 Update Novo Nordisk expands lawsuits against

The 6-month compounded semaglutide plan is $165 per month, and tirzepatide is $232 per month something branded medicines cannot match

Since the patent has lapsed, the CSP is no longer relevant. What Novo Nordisk stands to lose in Canada and beyond The expiry of Novo Nordisks semaglutide patent in Canada might look small on paper, but the consequences could be substantial

The distribution is striking

HPO, hypothalamicpituitaryovarian axis

For the last decade, the most powerful tools in weight loss medicine came with a prerequisite: a needle

(2019) Free fatty acid receptors, G protein-coupled receptor 120 and G protein-coupled receptor 40, are essential for oil-induced gastric inhibitory polypeptide secretion